Lexaria’s patented DehydraTECH technology is used to make better tasting, faster-acting, more potent cannabinoid edible products. Our technology combines molecules such as CBD or THC with select fatty acids to bypass human taste receptors in the mouth and influence faster more potent action in the human intestine. We licensed our technology to third-party manufacturers in the United States and look to grow revenues in this fashion globally. Soon consumers everywhere will demand a DehydraTECH in their edible product formulations.
Lexaria Bioscience Corp. has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules.
Many vitamins, drugs, supplements and other beneficial molecules are lipophilic (i.e. fat soluble) and difficult for the human gastrointestinal system to efficiently and effectively absorb. DehydraTECH™ greatly improves the body’s ability to absorb these substances so their benefits can be received more quickly and pleasantly.
Lexaria has multiple patents issued or pending in over 40 countries around the world.
For more information on Lexaria Bioscience (LXX.CN) please fill out the form below.